Reduction in the acquisition rate of carbapenem-resistant Acinetobacter baumannii (CRAB) after room privatization in an intensive care unit

被引:9
|
作者
Jung, J. [1 ]
Choe, P. G. [1 ,2 ]
Choi, S. [2 ]
Kim, E. [2 ]
Lee, H. Y. [2 ]
Kang, C. K. [1 ,2 ]
Lee, J. [1 ]
Park, W. B. [1 ,2 ]
Lee, S. [1 ]
Kim, N. J. [1 ,2 ]
Choi, E. H. [2 ,3 ]
Oh, M. [1 ,2 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Internal Med, 103 Daehak Ro, Seoul 03080, South Korea
[2] Seoul Natl Univ Hosp, Ctr Infect Control & Prevent, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea
关键词
ICU; Multi-drug resistance; Acinetobacter baumannii; Infection control; HAND HYGIENE COMPLIANCE; SINK LOCATION; HANDWASHING COMPLIANCE; RISK-FACTORS; WARD DESIGN; INFECTION; IMPACT; BACTERIA;
D O I
10.1016/j.jhin.2021.12.012
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Acinetobacter baumannii is one of the major pathogens responsible for healthcare-associated infections, especially in intensive care units (ICUs). Aim: To evaluate the effect of room privatization in an ICU on the acquisition of carbapenem-resistant A. baumannii (CRAB). Methods: Between March and August 2017, a medical ICU was renovated from a multi-bed bay room to single rooms. Acquisition of CRAB was compared between patients admitted to the ICU over 18 months pre-renovation (September 2015 to February 2017) and post-renovation (September 2017 to February 2019). A Cox proportional hazard model was used with adjustment for demographics and comorbidities. Findings: Of the 901 patients, who contributed 8276 patient-days, 95 (10.5%) acquired CRAB during their ICU stay. The CRAB acquisition rate was significantly higher during the pre-renovation period (1.87 per 100 patient-days) than during the post-renovation period (0.39 per 100 patient-days) (P<0.001). In the multi-variable Cox regression model, CRAB acquisition was significantly associated with the presence of a feeding tube (adjusted hazard ratio (aHR), 6.08; 95% confidence interval (CI), 2.46-15.06; P<0.001), continuous renal replacement therapy (aHR, 1.66; 95% CI, 1.09-2.53; P=0.019) and admission after renovation of the ICU to single rooms (aHR, 0.23; 95% CI, 0.12-0.41; P<0.001). Conclusions: Renovation of ICUs to single rooms is an efficient strategy to prevent transmission of multi-drug-resistant organisms and hospital-acquired infections. (C) 2021 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:14 / 21
页数:8
相关论文
共 50 条
  • [31] Molecular Epidemiological Investigation and Management of Outbreak Caused by Carbapenem-Resistant Acinetobacter baumannii in a Neonatal Intensive Care Unit
    Woon, Jia Jie
    Ahmad Kamar, Azanna
    Teh, Cindy Shuan Ju
    Idris, Nuryana
    Zhazali, Rosliza
    Saaibon, Suzana
    Basauhra Singh, Harvinderjit Kaur
    Charanjeet Singh, Jasreena Kaur Gill
    Kamarulzaman, Adeeba
    Ponnampalavanar, Sasheela
    MICROORGANISMS, 2023, 11 (04)
  • [32] Elimination of an outbreak of carbapenem-resistant Acinetobacter baumannii in a burn unit
    Havill, Nancy L.
    Samuels, Monique
    Poudyal, Anjali
    Sujanan, Vineetha
    Murdzek, Christina
    Aniskiewicz, Michael J.
    Maloney, Meghan
    Laird, Jacqueline
    Savetamal, Alisa
    AMERICAN JOURNAL OF INFECTION CONTROL, 2025, 53 (01) : 160 - 162
  • [33] Outbreak of carbapenem-resistant Acinetobacter baumannii among non-burn patients in a burn intensive care unit
    Gulati, R. K.
    Choudhuri, J.
    Fulton, C.
    Chan, J. D.
    Evans, H. L.
    Lynch, J. B.
    Dellit, T. H.
    JOURNAL OF HOSPITAL INFECTION, 2010, 76 (04) : 357 - 358
  • [34] Phenotypic and Molecular Characteristics of Carbapenem-Resistant Acinetobacter baumannii Isolates from Bulgarian Intensive Care Unit Patients
    Strateva, Tanya V.
    Sirakov, Ivo
    Stoeva, Temenuga J.
    Stratev, Alexander
    Peykov, Slavil
    MICROORGANISMS, 2023, 11 (04)
  • [35] Outbreak of carbapenem-resistant Acinetobacter baumannii in the intensive care unit: a multi-level strategic management approach
    Molter, G.
    Seifert, H.
    Mandraka, F.
    Kasper, G.
    Weidmann, B.
    Hornei, B.
    Oehler, M.
    Schwimmbeck, P.
    Kroeschel, P.
    Higgins, P. G.
    Reuter, S.
    JOURNAL OF HOSPITAL INFECTION, 2016, 92 (02) : 194 - 198
  • [36] Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii Isolated from Intensive Care Unit Patients in Jordanian Hospitals
    Al-Sheboul, Suhaila A.
    Al-Moghrabi, Salam Z.
    Shboul, Yasemin
    Atawneh, Farah
    Sharie, Ahmed H.
    Nimri, Laila F.
    ANTIBIOTICS-BASEL, 2022, 11 (07):
  • [37] Application of Bacteriophage-containing Aerosol against Nosocomial Transmission of Carbapenem-Resistant Acinetobacter baumannii in an Intensive Care Unit
    Ho, Yu-Huai
    Tseng, Chun-Chieh
    Wang, Lih-Shinn
    Chen, Yi-Ting
    Ho, Guan-Jin
    Lin, Teng-Yi
    Wang, Ling-Yi
    Chen, Li-Kuang
    PLOS ONE, 2016, 11 (12):
  • [38] Risk Factors for Occurrence and 30-Day Mortality for Carbapenem-Resistant Acinetobacter baumannii Bacteremia in an Intensive Care Unit
    Kim, Song Yee
    Jung, Ji Ye
    Kang, Young Ae
    Lim, Joo Eun
    Kim, Eun Young
    Lee, Sang Kook
    Park, Seon Cheol
    Chung, Kyung Soo
    Park, Byung Hoon
    Kim, Young Sam
    Kim, Se Kyu
    Chang, Joon
    Park, Moo Suk
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (08) : 939 - 947
  • [39] Community-acquired in name only: A cluster of carbapenem-resistant Acinetobacter baumannii in a burn intensive care unit and beyond
    Shenoy, Erica S.
    Pierce, Virginia M.
    Sater, Mohamad R. A.
    Pangestu, Febriana K.
    Herriott, Ian C.
    Anahtar, Melis N.
    Bramante, Juliet T.
    Kwon, Douglas S.
    Hawkins, Fred R., Jr.
    Suslak, Dolores
    West, Lauren R.
    Huntley, Miriam H.
    Hooper, David C.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 (05): : 531 - 538
  • [40] Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii Isolated from the Intensive Care Unit in a Tertiary Teaching Hospital in Malaysia
    Woon, Jia Jie
    Teh, Cindy Shuan Ju
    Chong, Chun Wie
    Abdul Jabar, Kartini
    Ponnampalavanar, Sasheela
    Idris, Nuryana
    ANTIBIOTICS-BASEL, 2021, 10 (11):